D'hondt N E, Struijs P A, Kerkhoffs G M, Verheul C, Lysens R, Aufdemkampe G, Van Dijk C N
Sports & Orthopaedic Rehabilitation Centre, Van Huis & Van't Kloosterv, Physiotherapists, Catharijnesingel 73, Utrecht, Netherlands.
Cochrane Database Syst Rev. 2002(2):CD002267. doi: 10.1002/14651858.CD002267.
Patellofemoral pain syndrome is a frequently reported condition in active adults. A wide variety of conservative treatment strategies have been described. As yet, no optimal strategy has been identified. Application of orthotic devices e.g. knee braces, knee straps, forms of taping of the knee, active training devices, knee sleeves and in-shoe orthotics to support the foot have been advocated to treat this condition.
To assess the effectiveness of foot and knee orthotics for treatment of patellofemoral pain syndrome.
We searched the Cochrane Musculoskeletal Injuries Group specialised register (December 2001), the Cochrane Controlled Trials register (Issue 2, 2000), MEDLINE (January 1966 to March 2000; EMBASE (January 1988 to March 2000); CINAHL (January 1982 to March 2000) and PEDro (up to March 2000). Relevant orthotic companies were contacted.
All randomised and quasi-randomised trials comparing the effectiveness of knee or foot orthotics for treatment of patellofemoral pain syndrome were selected. Trials describing the use of orthotic devices in conjunction with operative treatment were excluded.
Three reviewers independently assessed methodological quality of the identified trials by use of a modified version of the Cochrane Musculoskeletal Injuries Group assessment tool, consisting 11 items. Two reviewers extracted data without blinding. Trialists were contacted to obtain missing data.
Five trials involving 362 participants were included in this review. Five other trials await possible inclusion if further information can be obtained and one awaits further assessment. Due to clinical heterogeneity, we refrained from statistical pooling and conducted analysis by grading the strength of scientific evidence. The level of obtained research-based evidence was graded as limited as all trials were of low methodological quality. This limited research-based evidence showed the Protonics orthosis at six week follow-up was significantly more effective for decrease in pain (weighted mean difference (WMD) between groups 3.2; 95% confidence interval (CI) 2.8 to 3.6), functional improvement on the Kujala score (WMD 45.6; 95% CI 43.4 to 47.7) and change in patellofemoral congruence angle (WMD 17.2; 95% CI 14.1 to 20.3) when compared to no treatment. A comprehensive programme including tape application was significantly superior to a monitored exercise programme without tape application for decrease in worst pain (WMD 1.6; 95% CI 0.4 to 2.8) and usual pain (WMD 1.2; 95% CI 0.2 to 2.1), and clinical change and functional improvement questionnaire scores (WMD 10, 95% CI 2.07 to 17.93) at four weeks follow-up. The trials reported statistically significant differences in patient satisfaction after applied therapy (WMD 3.3; 95% CI 0.5 to 6.1) in favour of the McConnell regimen compared with the Coumans bandage at six weeks follow-up.
REVIEWER'S CONCLUSIONS: The evidence from randomised controlled trials is currently too limited to draw definitive conclusions about the use of knee and foot orthotics for the treatment of patellofemoral pain. Future high quality trials in this field are warranted.
髌股疼痛综合征在活跃的成年人中是一种经常被报道的病症。已经描述了各种各样的保守治疗策略。然而,尚未确定最佳策略。有人主张应用矫形器械,如膝关节支具、护膝带、膝关节绑扎形式、主动训练器械、护膝和鞋垫式矫形器来支撑足部以治疗这种病症。
评估足部和膝关节矫形器治疗髌股疼痛综合征的有效性。
我们检索了Cochrane肌肉骨骼损伤组专业注册库(2001年12月)、Cochrane对照试验注册库(2000年第2期)、MEDLINE(1966年1月至2000年3月)、EMBASE(1988年1月至2000年3月)、CINAHL(1982年1月至2000年3月)和PEDro(截至2000年3月)。并联系了相关的矫形器公司。
选择所有比较膝关节或足部矫形器治疗髌股疼痛综合征有效性的随机和半随机试验。排除描述矫形器械与手术治疗联合使用的试验。
三位评价者使用Cochrane肌肉骨骼损伤组评估工具的修改版(包括11项内容)独立评估所纳入试验的方法学质量。两位评价者在不设盲的情况下提取数据。与试验者联系以获取缺失数据。
本综述纳入了5项涉及362名参与者的试验。如果能获得更多信息,另外5项试验可能被纳入,1项试验有待进一步评估。由于临床异质性,我们没有进行统计合并,而是通过对科学证据的强度进行分级来进行分析。由于所有试验的方法学质量都很低,所获得的基于研究的证据水平被评为有限。这一有限的基于研究的证据表明,与不治疗相比,在六周随访时,Protonics矫形器在减轻疼痛方面显著更有效(组间加权平均差(WMD)为3.2;95%置信区间(CI)为2.8至3.6),在Kujala评分的功能改善方面(WMD为45.6;95%CI为43.4至47.7)以及在髌股适合角变化方面(WMD为17.2;95%CI为14.1至20.3)。在四周随访时,一个包括绑扎应用的综合方案在减轻最严重疼痛(WMD为1.6;95%CI为0.4至2.8)和通常疼痛(WMD为1.2;95%CI为0.2至2.1)以及临床变化和功能改善问卷评分方面(WMD为10,95%CI为2.07至17.93)显著优于不应用绑扎的监测运动方案。试验报告在六周随访时,应用治疗后患者满意度在统计学上有显著差异(WMD为3.3;95%CI为0.5至6.1),支持McConnell方案优于Coumans绷带。
目前来自随机对照试验的证据太有限,无法就使用膝关节和足部矫形器治疗髌股疼痛得出明确结论。该领域未来需要高质量的试验。